Present status and future perspectives on the tobacco and nicotine epidemic with a focus on men: a narrative review

Tobacco smoking is one of the main factors of disease burden worldwide. This narrative review presents an overview of this burden, focusing primarily on men. We also discuss the prevention strategies that have been implemented to address this issue, including tobacco control policies, steming mainly from the World Health Organization Framework Convention on Tobacco Control, as well as lung cancer screening programmes. Additionally, we comment on how the tobacco epidemic has given rise to the widespread use of nicotine due to the popularisation of novel nicotine and tobacco-related products, including electronic nicotine and non-nicotine delivery systems, heated tobacco and nicotine pouches.

Lung cancer; Male; Nicotine; Smoking; Tobacco control

[1] Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the global Burden of Disease Study 2019. The Lancet. 2021; 397: 2337–2360.

[2] Lopez Alan D, Collishaw Neil E, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tobacco Control. 1994; 3: 242–247.

[3] Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024; 403: 2162–2203.

[4] Goodchild M, Nargis N, Tursan d’Espaignet E. Global economic cost of smoking-attributable diseases. Tobacco Control. 2018; 27: 58–64.

[5] Shen M, Li Y, Song B, Zhou C, Gong J, Zeng G. Smoked cigarette butts: unignorable source for environmental microplastic fibers. The Science of the Total Environment. 2021; 791: 148384.

[6] World Health Organization. WHO Framework Convention on Tobacco Control. Overview. 2003. Available at: https://fctc.who.int/who-fctc/overview (Accessed: 14 February 2024).

[7] World Health Organization. MPOWER. 2023. Available at: https://www.who.int/initiatives/mpower (Accessed: 14 February 2024).

[8] World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. 2023. Available at: https://www.who.int/publications/i/item/9789240077164 (Accessed: 14 February 2024).

[9] Flor LS, Reitsma MB, Gupta V, Ng M, Gakidou E. The effects of tobacco control policies on global smoking prevalence. Nature Medicine. 2021; 27: 239–243.

[10] Paraje G, Flores Muñoz M, Wu DC, Jha P. Reductions in smoking due to ratification of the Framework Convention for Tobacco Control in 171 countries. Nature Medicine. 2024; 30: 683–689.

[11] World Health Organization. WHO global report on trends in prevalence of tobacco use 2000–2025, fourth edition. 2021. Available at: https://www.who.int/publications/i/item/9789240039322 (Accessed: 14 February 2024).

[12] Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018; 391: 1023–1075.

[13] Martín-Sánchez JC, Bilal U, Clèries R, Lidón-Moyano C, Fu M, González-de Paz L, et al. Modelling lung cancer mortality rates from smoking prevalence: fill in the gap. Cancer Epidemiology. 2017; 49: 19–23.

[14] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021; 71: 209–249.

[15] Diaz M, Garcia M, Vidal C, Santiago A, Gnutti G, Gómez D, et al. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: a model-based cost-effectiveness analysis. Lung Cancer. 2021; 159: 153–161.

[16] Reitsma M, Kendrick P, Anderson J, Arian N, Feldman R, Gakidou E, et al. Reexamining rates of decline in lung cancer risk after smoking cessation. A meta-analysis. Annals of the American Thoracic Society. 2020; 17: 1126–1132.

[17] Pinsky PF. Lung cancer screening with low-dose CT: a world-wide view. Translational Lung Cancer Research. 2018; 7: 234–242.

[18] National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. 2011; 365: 395–409.

[19] de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. The New England Journal of Medicine. 2020; 382: 503–513.

[20] United States Preventive Services Taskforce n.d. Lung Cancer: Screening. 2013. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-december-2013#fullrecommendationstart (Accessed: 29 May 2023).

[21] Sands J, Tammemägi MC, Couraud S, Baldwin DR, Borondy-Kitts A, Yankelevitz D, et al. Lung screening benefits and challenges: a review of the data and outline for implementation. Journal of Thoracic Oncology. 2021; 16: 37–53.

[22] Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database of Systematic Reviews. 2022; 8: CD013829.

[23] Council of the European Union. Council Recommendation of 9 December 2022 on strengthening prevention through early detection: A new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. 2022. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022H1213(01) (Accessed: 14 February 2024).

[24] US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021; 325: 962–970.

[25] Apollonio D, Glantz SA. Tobacco industry research on nicotine replacement therapy: “if anyone is going to take away our business it should be us”. American Journal of Public Health. 2017; 107: 1636–1642.

[26] Hatsukami DK, Carroll DM. Tobacco harm reduction: past history, current controversies and a proposed approach for the future. Preventive Medicine. 2020; 140: 106099.

[27] Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews. 2024; CD010216.

[28] Banks E, Yazidjoglou A, Brown S, Nguyen M, Martin M, Beckwith K, et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. The Medical Journal of Australia. 2023; 218: 267–275.

[29] Rebuli ME, Rose JJ, Noël A, Croft DP, Benowitz NL, Cohen AH, et al. The e-cigarette or vaping product use-associated lung injury epidemic: pathogenesis, management, and future directions: an official American thoracic society workshop report. Annals of the American Thoracic Society. 2023; 20: 1–17.

[30] Tattan-Birch H, Hartmann-Boyce J, Kock L, Simonavicius E, Brose L, Jackson S, et al. Heated tobacco products for smoking cessation and reducing smoking prevalence. The Cochrane Database of Systematic Reviews. 2022; 1: CD013790.

[31] Znyk M, Jurewicz J, Kaleta D. Exposure to heated tobacco products and adverse health effects, a systematic review. International Journal of Environmental Research and Public Health. 2021; 18: 6651.

[32] O’Brien D, Long J, Quigley J, Lee C, McCarthy A, Kavanagh P. Association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis. BMC Public Health. 2021; 21: 954.

[33] Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat-not-burn tobacco products: concerns from the Italian experience. Tobacco Control. 2019; 28: 113–114.

[34] European Commission. Attitudes of Europeans towards tobacco and electronic cigarettes. 2021. Available at: https://doi.org/10.2875/490366 (Accessed: 5 March 2021).

[35] European Commission. Europe’s beating cancer plan. Communication from the commission to the European Parliament and the Council. 2021. Available at: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf (Accessed: 10 May 2023).